Blog
Contact us today to speak with our team.
Posted on September 22, 2026 · 9 min read · Raechel
Hormone levels naturally change with age, but those changes do not affect everyone the same way. Some people experience mild symptoms, while others struggle with persistent hot flashes, sleep disruption, low libido, mood changes, fatigue, or changes in muscle mass and body composition.
If you've been researching perimenopause and menopause treatment options, you've likely encountered conflicting information about hormone therapy. Much of the concern surrounding hormone replacement therapy (HRT) can be traced to early interpretations of the Women's Health Initiative (WHI), a major study whose findings significantly changed how both patients and clinicians viewed hormone treatment.
Since then, additional research and closer analysis of the WHI data have provided important context, particularly around a woman's age, how long it has been since menopause began, the type of hormone therapy used, and her individual health history.
Bioidentical hormones are chemically identical to hormones naturally produced by the human body. For appropriate patients, prescription bioidentical hormone therapy may help address symptoms associated with menopause, perimenopause, low testosterone, or other medically confirmed hormone deficiencies. Understanding both the potential benefits and the factors that influence treatment safety can help you have a more informed conversation with your healthcare provider.
Bioidentical hormones are manufactured hormones that share the same molecular structure as hormones naturally produced in the body, including estrogen, progesterone, and testosterone.
One important distinction often causes confusion.
Some bioidentical hormone medications are FDA-approved and manufactured under strict quality standards. Others are compounded specifically for individual patients by specialized pharmacies. Compounded formulations are not FDA-approved and are not evaluated under the same standards for consistency, purity, or effectiveness as FDA-approved medications.
That distinction matters because "bioidentical" does not automatically mean safer, more natural, or more effective than traditional hormone therapy. Current medical evidence has not shown bioidentical hormones to be inherently safer simply because they are marketed as natural.
If you're exploring bioidentical hormone replacement therapy, understanding which type of medication is being prescribed is important.
Hormone therapy is typically considered when declining hormone levels begin affecting daily quality of life.
Women entering perimenopause or menopause may experience:
Hot flashes
Night sweats
Sleep disturbances
Mood changes
Brain fog
Vaginal dryness
Pain during intercourse
Low libido
Weight changes
Reduced bone density over time
Many women seek evaluation through hormone therapy for women when these symptoms begin interfering with everyday activities. Treatment decisions are based on symptoms, medical history, physical examination, and laboratory findings rather than age alone.
Women experiencing transitional symptoms may also benefit from evaluation through perimenopause and menopause treatment to determine whether hormone therapy or other therapies are appropriate.
Testosterone naturally declines with age, although not every man develops clinically significant low testosterone.
Symptoms that may warrant evaluation include:
Low energy
Reduced libido
Erectile dysfunction
Loss of muscle mass
Increased body fat
Reduced exercise performance
Difficulty concentrating
Mood changes
A comprehensive evaluation through hormone therapy for men helps determine whether symptoms are truly related to hormone deficiency or another underlying medical condition.
When prescribed appropriately and monitored carefully, bioidentical hormone therapy may improve symptoms caused by hormone deficiency.
Potential benefits may include:
Hormone therapy remains one of the most effective treatments for moderate to severe hot flashes and night sweats. Many patients also experience improvements in sleep quality when nighttime symptoms become less frequent.
For women experiencing vaginal dryness or discomfort during intimacy, hormone therapy may improve tissue health and reduce discomfort.
Some patients report improvements in energy, mental clarity, and mood after hormone levels are appropriately corrected. Results vary between individuals, and these improvements are not guaranteed.
When low hormone levels contribute to reduced libido, restoring hormone balance may improve sexual desire and overall sexual wellness in both men and women.
Patients experiencing sexual health concerns may also benefit from services focused on female sexual wellness or ED and low libido treatment for men, depending on the underlying cause.
For certain women, particularly around menopause, estrogen therapy may help slow bone loss and reduce future fracture risk when appropriate, based on individual risk factors.
For many women, concerns about hormone therapy can be traced back to the Women's Health Initiative (WHI), a large research initiative launched to study major health issues affecting postmenopausal women.
Early WHI findings published in the early 2000s raised concerns about breast cancer, cardiovascular disease, stroke, and blood clots associated with certain forms of hormone therapy. The findings received widespread media attention and led many women to stop hormone therapy or avoid it altogether.
However, the original headlines did not always capture the full context of the research. One important issue was the difference between relative and absolute risk. A percentage increase in relative risk can sound substantial without showing how many additional cases actually occurred among the women studied.
Age and timing also matter. Many women enrolled in the WHI were older and years beyond the onset of menopause, making the findings less directly applicable to younger women beginning treatment around the menopausal transition. Subsequent analyses have helped create a more nuanced understanding of hormone therapy, including the importance of a woman's age, time since menopause, treatment formulation, route of administration, and individual health risks.
The takeaway is not that hormone therapy is risk-free or appropriate for everyone. Rather, the WHI should not be interpreted to mean that hormone therapy is broadly unsafe for all women. Modern treatment decisions are individualized, with providers weighing potential benefits and risks based on each patient's health history, symptoms, age, and treatment goals.
Hormone therapy is not inherently "good" or "bad." Its benefits and risks depend on factors such as the patient's age, health history, symptoms, hormone formulation, dosage, route of administration, and how treatment is monitored. Understanding these considerations helps patients and providers determine when treatment may be appropriate.
Like any medication, hormone therapy can cause side effects.
Depending on the hormone being prescribed, possible side effects may include:
Breast tenderness
Bloating
Acne
Fluid retention
Mood changes
Headaches
Vaginal spotting
Changes in libido
Injection site irritation when injectable therapies are used
Some patients taking bioidentical progesterone may also experience fatigue, dizziness, or sleepiness, particularly during dose adjustments.
Most side effects can be managed with dosage changes or ongoing monitoring.
Certain medical conditions may make hormone therapy inappropriate or require additional caution.
These may include:
Certain breast cancers
Endometrial cancer
Active liver disease
History of blood clots
Stroke
Certain cardiovascular conditions
Unexplained vaginal bleeding
Your provider will carefully review your personal and family medical history before recommending treatment.
Hormone therapy safety cannot be reduced to a single risk profile. Potential risks vary based on the hormones used, dosage and delivery method, as well as a patient's age, health history, and timing of treatment.
Depending on these factors, certain hormone therapies may be associated with increased risks of blood clots, stroke, cardiovascular complications, or breast cancer in some patient populations. However, these risks are not identical for every patient or every type of hormone therapy.
This is one reason modern hormone therapy is individualized rather than approached as a one-size-fits-all treatment. A qualified healthcare provider can assess your personal and family medical history, determine whether treatment is appropriate, and recommend a formulation and monitoring plan based on your individual risk profile.
Compounded bioidentical hormones may be appropriate in certain situations, but patients should understand that they are not FDA-approved.
Because compounded medications are individually prepared, they are not subject to the same FDA review process for manufacturing consistency, dosage accuracy, or effectiveness as FDA-approved products.
Discussing why a compounded medication is recommended and how it will be monitored is an important part of informed decision-making.
Potential benefits include symptom relief, improved sleep, increased energy, enhanced libido, and better quality of life for appropriate candidates. Treatment is not appropriate for everyone. Potential drawbacks include side effects, medical risks, ongoing monitoring requirements, and cost considerations.
Current evidence has not shown that bioidentical hormones are inherently safer or more effective than traditional hormone therapy simply because they are bioidentical. Safety depends on the specific medication, dosage, patient health, and ongoing medical supervision.
Possible side effects include breast tenderness, bloating, acne, headaches, mood changes, fluid retention, spotting, and changes in libido. Side effects vary depending on the specific hormone used.
Individuals with certain cancers, active liver disease, unexplained vaginal bleeding, blood-clotting disorders, stroke history, or certain cardiovascular conditions may not be appropriate candidates. A healthcare provider should evaluate each case individually.
No. Compounded bioidentical hormones are customized by compounding pharmacies and are not FDA-approved. FDA-approved bioidentical hormone medications are available for certain hormones.
Hormone replacement therapy (HRT) is a broad term that includes many hormone medications. Bioidentical hormone replacement therapy (BHRT) specifically refers to hormones that are chemically identical to those naturally produced by the body.
For many appropriately selected women, hormone replacement therapy (HRT) can be a safe and effective treatment for menopausal symptoms. Safety depends on factors such as age, time since menopause, personal and family medical history, the type and dose of hormones used, and how they are administered.
Concerns about HRT were amplified by early reporting of the Women's Health Initiative, but subsequent research has provided a more nuanced understanding of who may benefit from treatment and who may face greater risks. HRT is not appropriate for every woman, which is why treatment should be individualized and prescribed and monitored by a qualified healthcare provider.
Choosing hormone therapy is an individualized medical decision that should be based on your symptoms, health history, laboratory findings, age, treatment goals, and personal risk factors.
For many patients, hormone therapy can provide meaningful symptom relief and quality-of-life benefits. While treatment does carry potential risks and is not appropriate for everyone, decades of additional research since the initial Women's Health Initiative findings have provided a more nuanced picture of hormone therapy safety.
Understanding the benefits, risks, and context behind common concerns about bioidentical hormones can help you make an informed decision rather than one based on outdated or generalized perceptions of HRT.
Book a consultation to discuss whether hormone therapy is appropriate for your health history, symptoms, and goals.
Raechel
Clinical Expert
Our care team is here to help — no pressure, just answers.